243 related articles for article (PubMed ID: 18187873)
1. Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas.
Morimoto R; Satoh F; Murakami O; Suzuki T; Abe T; Tanemoto M; Abe M; Uruno A; Ishidoya S; Arai Y; Takahashi K; Sasano H; Ito S
Endocr J; 2008 Mar; 55(1):49-55. PubMed ID: 18187873
[TBL] [Abstract][Full Text] [Related]
2. Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: Is there a correlation?
Das S; Sengupta M; Islam N; Roy P; Datta C; Mishra PK; Banerjee S; Chaudhuri MK; Chatterjee U
J Pediatr Surg; 2016 Nov; 51(11):1795-1800. PubMed ID: 27567308
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic utility of SF-1 in adrenal cortical tumours.
Maity P; Mondal A; Das R; Sengupta M; Gargari P; Kar A; Sarkar D; Mukhopadhyay S; Chowdhury S; Chatterjee U
Indian J Pathol Microbiol; 2022; 65(4):814-820. PubMed ID: 36308186
[TBL] [Abstract][Full Text] [Related]
4. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.
Beuschlein F; Weigel J; Saeger W; Kroiss M; Wild V; Daffara F; Libé R; Ardito A; Al Ghuzlan A; Quinkler M; Oßwald A; Ronchi CL; de Krijger R; Feelders RA; Waldmann J; Willenberg HS; Deutschbein T; Stell A; Reincke M; Papotti M; Baudin E; Tissier F; Haak HR; Loli P; Terzolo M; Allolio B; Müller HH; Fassnacht M
J Clin Endocrinol Metab; 2015 Mar; 100(3):841-9. PubMed ID: 25559399
[TBL] [Abstract][Full Text] [Related]
5. Adrenocortical Cancer: A 20-Year Experience of a Single Referral Center in Prognosis and Outcomes.
Parianos C; Kyriakopoulos G; Kostakis ID; Nasiri-Ansari N; Aggeli C; Dimitriadi A; Angelousi A; Papavassiliou AG; Kaltsas GA; Zografos G; Kassi E
Horm Metab Res; 2021 Nov; 53(11):709-716. PubMed ID: 34740271
[TBL] [Abstract][Full Text] [Related]
6. Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.
Sung TY; Choi YM; Kim WG; Lee YM; Kim TY; Shong YK; Kim WB; Song DE
J Korean Med Sci; 2017 May; 32(5):764-771. PubMed ID: 28378549
[TBL] [Abstract][Full Text] [Related]
7. Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma.
Poli G; Ruggiero C; Cantini G; Canu L; Baroni G; Armignacco R; Jouinot A; Santi R; Ercolino T; Ragazzon B; Assie G; Mannelli M; Nesi G; Lalli E; Luconi M
J Clin Endocrinol Metab; 2019 May; 104(5):1712-1724. PubMed ID: 30476173
[TBL] [Abstract][Full Text] [Related]
8. Histopathological study of adrenocortical carcinoma with special reference to the Weiss system and TNM staging and the role of immunohistochemistry to differentiate it from renal cell carcinoma.
Mondal SK; Dasgupta S; Jain P; Mandal PK; Sinha SK
J Cancer Res Ther; 2013; 9(3):436-41. PubMed ID: 24125979
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic role of SF1, IGF2, Ki67, p53, adiponectin, and leptin receptors in human adrenal cortical tumors.
Babińska A; Pęksa R; Wiśniewski P; Świątkowska-Stodulska R; Sworczak K
J Surg Oncol; 2017 Sep; 116(3):427-433. PubMed ID: 28672049
[TBL] [Abstract][Full Text] [Related]
10. IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours.
Schmitt A; Saremaslani P; Schmid S; Rousson V; Montani M; Schmid DM; Heitz PU; Komminoth P; Perren A
Histopathology; 2006 Sep; 49(3):298-307. PubMed ID: 16918977
[TBL] [Abstract][Full Text] [Related]
11. Low Protein Expression of both
Brondani VB; Lacombe AMF; Mariani BMP; Montenegro L; Soares IC; Bezerra-Neto JE; Tanno FY; Srougi V; Chambo JL; Mendonca BB; Almeida MQ; Zerbini MCN; Fragoso MCBV
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513905
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers.
Wang C; Sun Y; Wu H; Zhao D; Chen J
Histopathology; 2014 Mar; 64(4):567-76. PubMed ID: 24102952
[TBL] [Abstract][Full Text] [Related]
13. Minichromosome Maintenance Proteins MCM-3, MCM-5, MCM-7, and Ki-67 as Proliferative Markers in Adrenocortical Tumors.
Aporowicz M; Czopnik P; Kubicka E; Piotrowska A; Dziegiel P; Bolanowski M; Domoslawski P
Anticancer Res; 2019 Mar; 39(3):1151-1159. PubMed ID: 30842144
[TBL] [Abstract][Full Text] [Related]
14. Clinical Impact of Pathological Features Including the Ki-67 Labeling Index on Diagnosis and Prognosis of Adult and Pediatric Adrenocortical Tumors.
Martins-Filho SN; Almeida MQ; Soares I; Wakamatsu A; Alves VAF; Fragoso MCBV; Zerbini MCN
Endocr Pathol; 2021 Jun; 32(2):288-300. PubMed ID: 33443677
[TBL] [Abstract][Full Text] [Related]
15. Histopathological diagnosis and prognostic factors in adrenocortical carcinoma.
Aiba M; Fujibayashi M
Endocr Pathol; 2005; 16(1):13-22. PubMed ID: 16000842
[TBL] [Abstract][Full Text] [Related]
16. Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.
Pennanen M; Heiskanen I; Sane T; Remes S; Mustonen H; Haglund C; Arola J
Hum Pathol; 2015 Mar; 46(3):404-10. PubMed ID: 25582500
[TBL] [Abstract][Full Text] [Related]
17. Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma.
Duregon E; Molinaro L; Volante M; Ventura L; Righi L; Bolla S; Terzolo M; Sapino A; Papotti MG
Mod Pathol; 2014 Sep; 27(9):1246-54. PubMed ID: 24434900
[TBL] [Abstract][Full Text] [Related]
18. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.
Romero Arenas MA; Whitsett TG; Aronova A; Henderson SA; LoBello J; Habra MA; Grubbs EG; Lee JE; Sircar K; Zarnegar R; Scognamiglio T; Fahey TJ; Perrier ND; Demeure MJ
Ann Surg Oncol; 2018 Mar; 25(3):801-807. PubMed ID: 29218429
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features, biochemical and molecular markers in 5 patients with adrenocortical carcinoma.
Kouyama R; Hiraishi K; Sugiyama T; Izumiyama H; Yoshimoto T; Akashi T; Kihara K; Homma K; Shibata H; Hirata Y
Endocr J; 2011; 58(7):527-34. PubMed ID: 21521927
[TBL] [Abstract][Full Text] [Related]
20. Histone mRNA in situ hybridization and Ki 67 immunohistochemistry in pediatric adrenocortical tumors.
Orhan D; Kale G; Cağlar M; Göğüş S; Karaağaoğlu E
Virchows Arch; 2006 May; 448(5):591-6. PubMed ID: 16489441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]